Home
About
FAQ
History (28)
Anti-GD3 monoclonal antibody effects on lymphocytes and antibody-dependent cellular cytotoxicity.
A 10-day-old neonate with fulminant hepatitis.
Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat.
Cardiovascular magnetic resonance imaging: is only one shop worth the stop?
IMP-3 is a novel progression marker in malignant melanoma.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IMP-3 is a novel progression marker in malignant melanoma.
Pryor JG, Bourne PA, Yang Q, Spaulding BO, Scott GA, Xu H. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol. 2008 Apr; 21(4):431-7.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Diagnosis, Differential
Disease Progression
Female
Humans
Immunohistochemistry
Male
Melanoma
Middle Aged
Neoplasm Proteins
Nevus
Precancerous Conditions
RNA-Binding Proteins
Skin Neoplasms
authors with profiles
Haodong Xu MD, PhD